Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Mid Cap | Pharmaceuticals & Drugs
1458.45
2.20
(0.15%)
< Home
< Back
Cipla Ltd. News
>>
Cipla moves up on the BSE
>>
Cipla gains on granting global commercialization rights for nasal spray ‘Dymista’ to Meda
>>
Cipla grants global commercialization rights for nasal spray ‘Dymista’ to Meda
>>
Cipla submits disclosure
>>
Cipla reports 8% fall in Q4 net profit
>>
Cipla fixes Book Closure for Dividend & AGM
>>
CIpla finally gets Medpro’s shareholders approval for acquisition
>>
Cipla moves up on receiving A1+ rating for short-term debt programme from India Ratings
>>
India Ratings assigns A1+ rating to Cipla’s short-term debt programme
>>
Cipla inches up on launching the first Biosimilar of Etanercept in India
<<
<
93
94
95
...102
>
>>
2.20 (0.15%) 2.20 (0.15%)